Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-18

Clinical Trial Update: The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022

View source ↗

Summary

A SEER-based study (2000-2022) explores whether patients with a primary gastrointestinal carcinoid tumor have an increased risk of developing a second primary g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Suez Canal University | Conditions: Carcinoid Tumor, Second Primary Malignant Neoplasm | Status: COMPLETED